This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: Hokusai-VTE study

Insights in the treatment and prophylaxis of venous thromboembolism

July 2019 Br J Cardiol 2019;26(suppl 2):S15–S19 doi:10.5837/bjc.2019.s10

Insights in the treatment and prophylaxis of venous thromboembolism

Jecko Thachil

Abstract

Introduction Venous thromboembolism (VTE) is a common source of morbidity and mortality: for example, the annual incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in the UK have been estimated as 1/10,000 and 3–4/10,000 individuals, respectively, although the latter figure is considered to be an underestimate.1,2 The majority of cases of VTE occur during or following hospitalisation, and VTE has been described as the primary source of avoidable mortality in hospital;3 accordingly, more than 95% of such patients received a VTE risk assessment in 2016.4 Vitamin K antagonists (VKA), the standard of care for managing VTE for

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now